Skip to main content
DNTH filings

Corporate insider profile

Adam M Veness Filing Activity

Latest reported as SVP, General Counsel and Sec. of Dianthus Therapeutics, Inc. /DE/ (DNTH).

Purchase filings
0
Reported companies
1
Net open-market value
-$2,423,958.00
Latest transaction
Jun 17, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 17, 2026Dianthus Therapeutics, Inc. /DE/ (DNTH)SVP, General Counsel and Sec.Sale30,000$80.80$2,423,958